SABCS

VOIce For Life: Founder of MetaVivor, Dian “CJ” Corneliussen-James
Jun
07
2013

“CJ” retired from the Air Force in 2003 after serving 24 years as an intelligence officer. She then continued to work for the federal government in a civilian capacity until 2007 when complications from metastatic breast cancer cut her career short. CJ’s positions included, amongst others, monitoring and analyzing Soviet satellite activity during the Cold […]

Read More
The Group Room Interviews at the 2012 San Antonio Breast Cancer Symposium
Mar
04
2013

  Advocacy and educational support provided in part by:

Read More
Stefan Gluck, MD: Personalized Medicine and Tissue Collection For Cancer Research
Mar
04
2013

Dr. Stefan Gluck sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss personalized medicine as well as the need for more efficient tissue and biospecimen collection for cancer research. Stefan Gluck, MD is a Professor of Medicine, University of Miami, Associate Division […]

Read More
Christopher Twelves, MD: Comparing Eribulin and Capecitabine
Mar
04
2013

Dr. Christopher Twelves sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss the results of the Phase III clinical trial comparing capecitabine (Xeloda) and eribulin (Halaven).  The trial showed trends toward the superiority of eribulin in this setting but the results were […]

Read More
Joanne Mortimer, MD: Functional imaging Of HER2-positive Metastatic Breast Cancer
Mar
04
2013

Dr. Joanne Mortimer sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss research being conducted at the City Of Hope Cancer Center on the functional imaging of HER2-positive metastatic breast cancer. Joanne Mortimer, MD is the Vice Chair, Medical Oncology & Therapeutics […]

Read More
Richard S. Finn, MD: The Combination Of PD 0332991 and Letrozole Phase II Results
Mar
03
2013

Dr. Richard S. Finn sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss  the combination of PD 0332991 and letrozole phase II clinical trial results. Richard S. Finn, MD is Associate Professor at the Jonsson Comprehensive Cancer Center at UCLA. Advocacy and […]

Read More
Martine Piccart, MD, PhD: Can Patients and Advocates Help With Tissue and Biospecimen Collection?
Mar
03
2013

Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss how cancer patients and advocates can help lead the way for tissue and biospecimen collection for cancer research. Martine Piccart, MD, PhD is the current President of the European Society […]

Read More
Martine Piccart, MD, PhD: No Benefit in Extending Herceptin in HER2 Breast Cancer
Mar
03
2013

Dr. Martine Piccart sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss the results of a study she authored for patients with human epidermal growth factor receptor 2 (HER2)–positive early–stage breast cancer — one year of adjuvant trastuzumab (Herceptin) should remain the […]

Read More
Edith Perez, MD: Anti-HER2 Therapies
Mar
03
2013

Dr. Edith Perez sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).  They discuss her recent research with Anti-HER2 therapies presented at SABCS 2012. Edith A. Perez, MD is Deputy Director, Mayo Clinic Cancer Center — Group Vice Chair, Alliance for Clinical Trials in […]

Read More
Larry Norton, MD: The Rapidly Changing Face of Oncology
Mar
03
2013

Dr. Larry Norton sits down with Selma Schimmel and The Group Room at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) for a three-part interview.  This is the first in the three-part interview where he discusses the rapidly changing face of oncology and personalized medicine. Larry Norton, MD is the Deputy Physician-in-Chief for […]

Read More